Nikko Asset Management Americas’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$488K Sell
30,137
-1,670
-5% -$43.7K 0.01% 179
2025
Q4
$652K Sell
31,807
-3,035
-9% -$44.3K 0.01% 175
2025
Q3
$314K Sell
34,842
-9,086
-21% -$65.1K ﹤0.01% 191
2025
Q2
$141K Hold
43,928
﹤0.01% 190
2025
Q1
$184K Sell
43,928
-7,711
-15% -$48.2K ﹤0.01% 187
2024
Q4
$349K Sell
51,639
-2,664
-5% -$12.3K ﹤0.01% 177
2024
Q3
$178K Sell
54,303
-1,943
-3% -$10.7K ﹤0.01% 187
2024
Q2
$354K Sell
56,246
-2,897
-5% -$22.1K ﹤0.01% 187
2024
Q1
$420K Sell
59,143
-7,564
-11% -$63.1K ﹤0.01% 187
2023
Q4
$634K Hold
66,707
0.01% 183
2023
Q3
$634K Hold
66,707
0.01% 185
2023
Q2
$1.44M Buy
66,707
+1,095
+2% +$29.1K 0.02% 162
2023
Q1
$1.78M Sell
65,612
-5,791
-8% -$173K 0.02% 150
2022
Q4
$1.59M Sell
71,403
-2,780
-4% -$63.4K 0.02% 160
2022
Q3
$1.71M Sell
74,183
-1,117
-1% -$36K 0.02% 160
2022
Q2
$2.2M Sell
75,300
-137,351
-65% -$6.13M 0.03% 156
2022
Q1
$20M Buy
212,651
+95,397
+81% +$8.29M 0.15% 82
2021
Q4
$12K Buy
117,254
+25,311
+28% +$3.47M ﹤0.01% 204
2021
Q3
$16.1M Buy
91,943
+15,793
+21% +$3.51M 0.07% 104
2021
Q2
$21.7M Sell
76,150
-10,184
-12% -$3.01M 0.09% 96
2021
Q1
$23.2M Buy
86,334
+46,205
+115% +$14.1M 0.11% 98
2020
Q4
$9.27M Buy
+40,129
New +$10.8M 0.05% 129

Other funds holding BNR

Nikko Asset Management Americas's BNR Position: Q1 2026 in Review

Nikko Asset Management Americas reduced its Burning Rock Biotech (BNR) stake by 5.3% in Q1 2026, selling an estimated $43.7K and leaving 30,137 shares worth $488K. The position accounts for 0.01% of the portfolio, ranked #179.

Nikko Asset Management Americas first reported a position in BNR in Q4 2020 and has held it in 22 quarters since. The position peaked at $23.2M in Q1 2021. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • Nikko Asset Management Americas held 30,137 shares of Burning Rock Biotech worth $488K as of Q1 2026.
  • Nikko Asset Management Americas sold 1,670 Burning Rock Biotech shares in Q1 2026, an estimated $43.7K.
  • Burning Rock Biotech made up 0.01% of Nikko Asset Management Americas's portfolio in Q1 2026, its #179 holding.
  • Nikko Asset Management Americas first reported a position in Burning Rock Biotech in Q4 2020 and has held it in 22 quarters since.
  • Nikko Asset Management Americas's Burning Rock Biotech position peaked at $23.2M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on Nikko Asset Management Americas's 13F filing for Q1 2026, filed 7 May 2026.